Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Supervised Machine Learning Approach to Identify Early Predictors of Poor Outcome in Patients with COVID-19 Presenting to a Large Quaternary Care Hospital in New York City.
Zucker J, Gomez-Simmonds A, Purpura LJ, Shoucri S, LaSota E, Morley NE, Sovic BW, Castellon MA, Theodore DA, Bartram LL, Miko BA, Scherer ML, Meyers KA, Turner WC, Kelly M, Pavlicova M, Basaraba CN, Baldwin MR, Brodie D, Burkart KM, Bathon J, Uhlemann AC, Yin MT, Castor D, Sobieszczyk ME. Zucker J, et al. Among authors: pavlicova m. J Clin Med. 2021 Aug 11;10(16):3523. doi: 10.3390/jcm10163523. J Clin Med. 2021. PMID: 34441819 Free PMC article.
Quetiapine treatment for cannabis use disorder.
Mariani JJ, Pavlicova M, Jean Choi C, Basaraba C, Carpenter KM, Mahony AL, Brooks DJ, Bisaga A, Naqvi N, Nunes EV, Levin FR. Mariani JJ, et al. Among authors: pavlicova m. Drug Alcohol Depend. 2021 Jan 1;218:108366. doi: 10.1016/j.drugalcdep.2020.108366. Epub 2020 Oct 20. Drug Alcohol Depend. 2021. PMID: 33153828 Clinical Trial.
Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial.
Levin FR, Mariani JJ, Pavlicova M, Choi CJ, Basaraba C, Mahony AL, Brooks DJ, Naqvi N, Bisaga A. Levin FR, et al. Among authors: pavlicova m. Drug Alcohol Depend. 2021 Feb 1;219:108482. doi: 10.1016/j.drugalcdep.2020.108482. Epub 2021 Jan 5. Drug Alcohol Depend. 2021. PMID: 33418204 Free PMC article. Clinical Trial.
Non-abstinent treatment outcomes for cannabis use disorder.
Levin FR, Mariani JJ, Choi CJ, Basaraba C, Brooks DJ, Brezing CA, Pavlicova M. Levin FR, et al. Among authors: pavlicova m. Drug Alcohol Depend. 2021 Aug 1;225:108765. doi: 10.1016/j.drugalcdep.2021.108765. Epub 2021 May 21. Drug Alcohol Depend. 2021. PMID: 34087745 Free PMC article.
Cocaine use disorder patients develop distinct patterns of regulation of acth secretion by a vasopressin agonist and oxytocin: Report on a laboratory study.
Raby WN, Heller M, Milliaressis D, Choi CJ, Basaraba C, Levin FR, Church S, Pavlicova M, Nunes EV. Raby WN, et al. Among authors: pavlicova m. Drug Alcohol Depend Rep. 2023 Apr 11;7:100158. doi: 10.1016/j.dadr.2023.100158. eCollection 2023 Jun. Drug Alcohol Depend Rep. 2023. PMID: 37397438 Free PMC article.
123 results